|
Number |
Subject |
| 16-1 | Healthcare/Nursing Services for Individuals Receiving DDS Individualized Home Supports (IHS) |
| Attachment - |
| Attachment A - Minimum Preventative Care Guidelines for Persons with Intellectual/Developmental Disabilities |
| Deferred Limited and Declined Care Review Form |
| Health Care Coordination Guidelines |
| 16-1 Health Standard IHS PowerPoint Presentation |
| 14-1 | Interpretive Guidelines for the DDS Regulations Concerning the Administration of Medication by Certified Unlicensed Personnel. Replaces Medical Advisory 89-1, 93-1, 97-1, 99-3 |
|
13-01 |
|
|
Attachment -
|
|
09-2 |
Guidelines for Deferred, Limited, or Declined Healthcare |
|
Deferred Limited and Declined Care Progress Note |
|
Deferred Limited and Declined Care Review Form |
|
09-1 |
|
|
Attachment A - Minimum Preventative Care Guidelines for Persons with Intellectual/Developmental Disabilities |
|
Attachment B - Health Problem and Health History List |
|
Attachment C - Family Health History Form |
|
07-1 |
Health Standard #07-1 Dysphagia |
|
2000-2
|
Monitoring for Abnormal Involuntary Movements (Tardive Dyskinesia Screening) |
|
2000-1 |
Infection Control |
|
99-4 |
End of Life Decisions to Withhold and/or Withdraw Medical Treatment (As of 5/26/2004, Replaced by DDS Procedure:
|
|
99-3 |
Replaced by Medical Advisory 14-1 |
|
99-2 |
Replaced by Health Standard 09-1 |
|
99-1 |
Replaced by Health Standard 07-1 |
|
98-8 |
Replaced by Health Standard 09-1 |
|
98-7 |
Recommendations to Prevent Aspiration Pneumonia* |
|
98-6 |
Guidelines for Neurological Care of DDS Clients with Epilepsy* |
|
98-5 |
Standards for Multiple Psychotropic Drug Use* |
|
98-4 |
Health Promotion and Disease Prevention in Older Adults* |
|
98-3
|
Practical Guidelines for Care of Persons with Down Syndrome and Dementia |
|
98-2
|
Guidelines for Management of Clients with Vancomycin Resistant Enterococci in DDS Operated or Funded Facilities or Programs * |
|
98-1
|
Guidelines for Management of Individuals with Methicillin- Resistant Staphylococcus aureus in DDS Operated or Funded Facilities or Programs* |
|
97-3
|
Guidelines for Prevention of Bloodborne Pathogens (HIV & HBV) for DDS Clients* |
|
97-2
|
Advance Directive for DDS Clients (As of 5/26/04, Replaced by DDS Procedure: I.E.PR.007a) |
|
92-2
|
Monitoring the Use of Psychotropic Medication Prescribed for DDS Clients* |
|
91-4
|
Reporting Deaths of DDS Clients to the Office of the Chief Medical Examiner (As of 3/15/02, Replaced by DDS Procedure: I.D.PR.003) |
|
91-3 |
Autopsies (As of 3/15/02, Replaced by DDS Procedure: I.D.PR.004) |
|
91-2 |
Unlabeled Use of Medications for their Behavior Modifying Effects for DDS Clients* |
|
91-1 |
Neuroleptic Dose Reduction* |
|
87-2
|
Withholding Cardiopulmonary Resuscitation of Terminally Ill DDS Clients (As of 5/26/04, Replaced by DDS Procedure: I.E.PR.007.c) |
